Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.

Protein kinase CK2 (formerly casein kinase 2 or II) is a ubiquitous and highly conserved protein Ser/Thr kinase that plays diverse roles such as in cell proliferation and apoptosis. With respect to the latter, we originally showed that elevated CK2 could suppress various types of apoptosis in prostate cancer cells; however, the downstream pathways that respond to CK2 for mediating the suppression of apoptosis have not been fully elucidated. Here, we report studies on the role of CK2 in influencing activities associated with tumor necrosis factor-related ligand (TRAIL/Apo2-L)-mediated apoptosis in prostate carcinoma cells. To that end, we show that both androgen-insensitive (PC-3) and androgen-sensitive (ALVA-41) prostate cancer cells are sensitized to TRAIL by chemical inhibition of CK2 using its specific inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB). Furthermore, we have shown that overexpression of CK2alpha using pcDNA6-CK2alpha protected prostatic cancer cells from TRAIL-mediated apoptosis by affecting various activities associated with this process. Thus, overexpression of CK2 resulted in the suppression of TRAIL-induced apoptosis via its effects on the activation of caspases, DNA fragmentation, and downstream cleavage of lamin A. In addition, the overexpression of CK2 blocked the mitochondrial apoptosis machinery engaged by TRAIL. These findings define the important role of CK2 in TRAIL signaling in androgen-sensitive and -insensitive prostatic carcinoma cells. Our data support the potential usefulness of anticancer strategies that may involve the combination of TRAIL and down-regulation of CK2.

[1]  G. Unger,et al.  Targeting CK2 for cancer therapy. , 2005, Anti-cancer drugs.

[2]  G. Unger,et al.  Downregulation of CK2 induces apoptosis in cancer cells – A potential approach to cancer therapy , 2005, Molecular and Cellular Biochemistry.

[3]  K. Ahmed,et al.  Modulation of death receptor-mediated apoptosis by CK2 , 2005, Molecular and Cellular Biochemistry.

[4]  J. Houghton,et al.  Casein kinase II (CK2) enhances death-inducing signaling complex (DISC) activity in TRAIL-induced apoptosis in human colon carcinoma cell lines , 2005, Oncogene.

[5]  C. Belka,et al.  Type I and type II reactions in TRAIL-induced apoptosis – results from dose–response studies , 2005, Oncogene.

[6]  G. Unger,et al.  Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model. , 2004, Molecular cancer research : MCR.

[7]  Hongmei Yang,et al.  Persistent c-FLIP(L) Expression Is Necessary and Sufficient to Maintain Resistance to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand–Mediated Apoptosis in Prostate Cancer , 2004, Cancer Research.

[8]  J. Houghton,et al.  Influence of Casein Kinase II in Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Rhabdomyosarcoma Cells , 2004, Clinical Cancer Research.

[9]  Henning Walczak,et al.  The interplay between the Bcl-2 family and death receptor-mediated apoptosis. , 2004, Biochimica et biophysica acta.

[10]  G. Unger,et al.  Protein kinase CK2 as regulator of cell survival: implications for cancer therapy. , 2004, Current cancer drug targets.

[11]  R. Eils,et al.  Genome-wide expression screens indicate a global role for protein kinase CK2 in chromatin remodeling , 2003, Journal of Cell Science.

[12]  L. Pinna.  Protein kinase CK2: a challenge to canons , 2002, Journal of Cell Science.

[13]  R. Ravi,et al.  Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. , 2002, Cancer research.

[14]  L. Pinna,et al.  Protein kinase CK2 inhibitor 4,5,6,7-tetrabromobenzotriazole (TBB) induces apoptosis and caspase-dependent degradation of haematopoietic lineage cell-specific protein 1 (HS1) in Jurkat cells. , 2002, The Biochemical journal.

[15]  K. Ahmed,et al.  Joining the cell survival squad: an emerging role for protein kinase CK2. , 2002, Trends in cell biology.

[16]  K. Ahmed,et al.  Response of cancer cells to molecular interruption of the CK2 signal , 2001, Molecular and Cellular Biochemistry.

[17]  K. Ahmed,et al.  Consequences of CK2 signaling to the nuclear matrix. , 2001 .

[18]  C. Belka,et al.  Sensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL , 2001, Oncogene.

[19]  S. Yu,et al.  Protein kinase CK2 signal in neoplasia. , 2001, Histology and histopathology.

[20]  Chuan-hai Guo,et al.  A Potential Role of Nuclear Matrix-associated Protein Kinase CK2 in Protection against Drug-induced Apoptosis in Cancer Cells* , 2001, The Journal of Biological Chemistry.

[21]  E. Bruckheimer,et al.  Cell proliferation and apoptosis in prostate cancer: significance in disease progression and therapy. , 2000, Histology and histopathology.

[22]  M. Montenarh,et al.  Subcellular localization of protein kinase CK2 , 2000, Cell and Tissue Research.

[23]  E. Bruckheimer,et al.  Apoptosis in prostate carcinogenesis , 2000, Cell and Tissue Research.

[24]  S. Yu,et al.  Nuclear matrix targeting of the protein kinase CK2 signal as a common downstream response to androgen or growth factor stimulation of prostate cancer cells. , 1999, Cancer research.

[25]  O. Issinger,et al.  Protein kinase CK2 and its role in cellular proliferation, development and pathology , 1999, Electrophoresis.

[26]  A. Evdokiou,et al.  Death to the bad guys: Targeting cancer via Apo2L/TRAIL , 2005, Apoptosis.

[27]  D. Litchfield.  Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. , 2003, The Biochemical journal.

[28]  K. Ackermann,et al.  The genes encoding human protein kinase CK2 and their functional links. , 2003, Progress in nucleic acid research and molecular biology.

[29]  K. Ahmed,et al.  Significance of protein kinase CK2 nuclear signaling in neoplasia , 2000, Journal of cellular biochemistry. Supplement.

[30]  D. Seldin,et al.  Murine protein kinase CK2: gene and oncogene. , 1999 .